Revelation Biosciences Inc (REVB)
1.86
-0.09
(-4.62%)
USD |
NASDAQ |
May 16, 16:00
1.94
+0.08
(+4.30%)
After-Hours: 20:00
Revelation Biosciences Price to Book Value: 0.3206 for May 16, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 16, 2024 | 0.3206 |
| May 15, 2024 | 0.3361 |
| May 14, 2024 | 0.318 |
| May 13, 2024 | 0.3172 |
| May 10, 2024 | 0.3551 |
| May 09, 2024 | 0.3792 |
| May 08, 2024 | 0.3844 |
| May 07, 2024 | 0.4102 |
| May 06, 2024 | 0.4051 |
| May 03, 2024 | 0.4085 |
| May 02, 2024 | 0.4051 |
| May 01, 2024 | 0.3706 |
| April 30, 2024 | 0.3632 |
| April 29, 2024 | 0.3654 |
| April 26, 2024 | 0.3758 |
| April 25, 2024 | 0.3689 |
| April 24, 2024 | 0.3603 |
| April 23, 2024 | 0.3568 |
| April 22, 2024 | 0.3534 |
| April 19, 2024 | 0.3861 |
| April 18, 2024 | 0.3861 |
| April 17, 2024 | 0.3706 |
| April 16, 2024 | 0.3292 |
| April 15, 2024 | 0.3146 |
| April 12, 2024 | 0.3585 |
| Date | Value |
|---|---|
| April 11, 2024 | 0.3999 |
| April 10, 2024 | 0.3982 |
| April 09, 2024 | 0.4189 |
| April 08, 2024 | 0.4482 |
| April 05, 2024 | 0.4602 |
| April 04, 2024 | 0.4689 |
| April 03, 2024 | 0.4482 |
| April 02, 2024 | 0.4464 |
| April 01, 2024 | 0.4585 |
| March 28, 2024 | 0.673 |
| March 27, 2024 | 0.5969 |
| March 26, 2024 | 0.6386 |
| March 25, 2024 | 0.5871 |
| March 22, 2024 | 0.5822 |
| March 21, 2024 | 0.6018 |
| March 20, 2024 | 0.5969 |
| March 19, 2024 | 0.56 |
| March 18, 2024 | 0.5871 |
| March 15, 2024 | 0.1437 |
| March 14, 2024 | 0.1407 |
| March 13, 2024 | 0.155 |
| March 12, 2024 | 0.186 |
| March 11, 2024 | 0.2004 |
| March 08, 2024 | 0.2027 |
| March 07, 2024 | 0.2027 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.1227
Minimum
Feb 02 2024
9.701
Maximum
Feb 13 2023
1.602
Average
0.5186
Median
Jun 30 2023
Price to Book Value Benchmarks
| Cardiff Oncology Inc | 2.751 |
| Ocular Therapeutix Inc | 2.386 |
| Ocugen Inc | 16.84 |
| Cue Biopharma Inc | 2.818 |
| Solid Biosciences Inc | 2.784 |
Price to Book Value Related Metrics
| Price | 1.86 |
| Earnings Yield | -1.66K% |
| Market Cap | 3.037M |